|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/36 | |||
| A61K 47/42 | |||
| A61K 39/00 | |||
| A61K 39/395 | |||
| C07K 16/00 | |||
| C07K 16/06 | |||
| C12N 9/24 |
| (11) | Number of the document | 2477603 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10760140.3 |
| Date of filing the European patent application | 2010-09-16 | |
| (97) | Date of publication of the European application | 2012-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/002545 |
| Date | 2010-09-16 |
| (87) | Number | WO 2011/034604 |
| Date | 2011-03-24 |
| (30) | Number | Date | Country code |
| 277045 P | 2009-09-17 | US |
| (72) |
TESCHNER, Wolfgang, AT
SVATOS, Sonja, AT
BRUCKSCHWAIGER, Leopold, AT
WEBER, Alfred, AT
SCHWARZ, Hans-Peter, AT
LEI, Laura, US
|
| (73) |
Baxalta GmbH,
Thurgauerstrasse 130, 8152 Glattpark, Opfikon,
CH
Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn, IL 60015, US |
| (54) | STABLE CO-FORMULATION OF HYALURONIDASE AND IMMUNOGLOBULIN, AND METHODS OF USE THEREOF |
| STABLE CO-FORMULATION OF HYALURONIDASE AND IMMUNOGLOBULIN, AND METHODS OF USE THEREOF |